Dr Rer Nat Jonathan Josephs-Spaulding
- Bioinformatician (Translational Pharmacology Lab)
- Affiliate (School of Molecular Biosciences)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Renz, A. et al. (2025) Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses. Communications Biology, 8(1), 791. (doi: 10.1038/s42003-025-08148-y) (PMID:40410544) (PMCID:PMC12102274)
Josephs-Spaulding, J. et al. (2024) Reconstructing the transcriptional regulatory network of probiotic L. reuteri is enabled by transcriptomics and machine learning. mSystems, 9(3), e0125723. (doi: 10.1128/msystems.01257-23) (PMID:38349131) (PMCID:PMC10949432)
Forero-Rodríguez, Lady Johanna, Josephs-Spaulding, Jonathan, Flor, Stefano, Pinzón, Andrés and Kaleta, Christoph (2021) Parkinson’s disease and the metal–microbiome–gut–brain axis: a systems toxicology approach. Antioxidants, 11(1), 71. (doi: 10.3390/antiox11010071) (PMID:35052575) (PMCID:PMC8773335)
Josephs-Spaulding, Jonathan, Krogh, Thøger Jensen, Rettig, Hannah Clara, Lyng, Mark, Chkonia, Mariam, Waschina, Silvio, Graspeuntner, Simon, Rupp, Jan, Møller-Jensen, Jakob and Kaleta, Christoph (2021) Recurrent urinary tract infections: unraveling the complicated environment of uncomplicated rUTIs. Frontiers in Cellular and Infection Microbiology, 11, 562525. (doi: 10.3389/fcimb.2021.562525) (PMID:34368008) (PMCID:PMC8340884)
Josephs-Spaulding, Jonathan and Singh, Om V. (2021) Medical device sterilization and reprocessing in the era of multidrug-resistant (MDR) bacteria: issues and regulatory concepts. Frontiers in Medical Technology, 2, 587352. (doi: 10.3389/fmedt.2020.587352) (PMID:35047882) (PMCID:PMC8757868)
Bernardes, J. P. et al. (2020) Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity, 53(6), 1296-1314.e9. (doi: 10.1016/j.immuni.2020.11.017) (PMID:33296687) (PMCID:PMC7689306)
Renz, A. et al. (2025) Metabolic modeling elucidates phenformin and atpenin A5 as broad-spectrum antiviral drugs against RNA viruses. Communications Biology, 8(1), 791. (doi: 10.1038/s42003-025-08148-y) (PMID:40410544) (PMCID:PMC12102274)
Josephs-Spaulding, J. et al. (2024) Reconstructing the transcriptional regulatory network of probiotic L. reuteri is enabled by transcriptomics and machine learning. mSystems, 9(3), e0125723. (doi: 10.1128/msystems.01257-23) (PMID:38349131) (PMCID:PMC10949432)
Forero-Rodríguez, Lady Johanna, Josephs-Spaulding, Jonathan, Flor, Stefano, Pinzón, Andrés and Kaleta, Christoph (2021) Parkinson’s disease and the metal–microbiome–gut–brain axis: a systems toxicology approach. Antioxidants, 11(1), 71. (doi: 10.3390/antiox11010071) (PMID:35052575) (PMCID:PMC8773335)
Josephs-Spaulding, Jonathan, Krogh, Thøger Jensen, Rettig, Hannah Clara, Lyng, Mark, Chkonia, Mariam, Waschina, Silvio, Graspeuntner, Simon, Rupp, Jan, Møller-Jensen, Jakob and Kaleta, Christoph (2021) Recurrent urinary tract infections: unraveling the complicated environment of uncomplicated rUTIs. Frontiers in Cellular and Infection Microbiology, 11, 562525. (doi: 10.3389/fcimb.2021.562525) (PMID:34368008) (PMCID:PMC8340884)
Josephs-Spaulding, Jonathan and Singh, Om V. (2021) Medical device sterilization and reprocessing in the era of multidrug-resistant (MDR) bacteria: issues and regulatory concepts. Frontiers in Medical Technology, 2, 587352. (doi: 10.3389/fmedt.2020.587352) (PMID:35047882) (PMCID:PMC8757868)
Bernardes, J. P. et al. (2020) Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity, 53(6), 1296-1314.e9. (doi: 10.1016/j.immuni.2020.11.017) (PMID:33296687) (PMCID:PMC7689306)